Search

  • Sort by

  • Category

  • Post Type

  • Reset

Colorado’s March 2025 Amended SIP Application

April 2, 2025
Posted in

The state of Colorado submitted a revised application to the U.S. Food and Drug Administration to operation a Canadian drug importation plan in March. This blog post examines how the state’s application has changed over the years.

Read More

FOIA Returns from towns using Alternative Funding Vendors

April 1, 2025
Posted in

PSM has sent open records requests to several towns and schools with self-funded health plans about their relationships with Alternative Funding Vendors.

Read More

Colorado Department of Regulatory Agencies updates Joint Budget Committee on litigation costs

April 1, 2025
Posted in

A March 12, 2025 memo said the state had paid more than $150,000 defending itself in a lawsuit Amgen had filed over plans to set an upper payment limit on its rheumatoid arthritis treatment, Enbrel.

Read More

March 31, 2025: Senator asks how FDA will be accountable for unregulated active pharmaceutical ingredient (API) imports

March 31, 2025
Posted in ,

Senator Jim Banks asked pointed questions about how FDA will stem the tide of semaglutide and tirzepatide coming from unknown facilities.

Read More

Handout: Illegal ingredients linked to knockoff weight loss drugs pouring in from foreign sources

March 26, 2025
Posted in

Compounded versions of GLP-1 injectable treatments for diabetes and obesity have surged in popularity despite a lack the safety and efficacy assurances. The FDA has warned that these knockoff versions sometimes contain illicit semaglutide or tirzepatide-the active pharmaceutical ingredients (APIs) in weight loss drugs. Working with George Karavetsos, former director of FDA’s Office of Criminal Investigations and a federal prosecutor,…

Read More

March 24, 2025: Cost-saving AFPs are exposing Americans to risky, unregulated medicine

March 24, 2025
Posted in

“Alternative funding programs” are shifting expensive prescription coverage to illegal drug importation schemes.

Read More

Our Policy Focus: Protect Patients

March 24, 2025

Our policy focus: protect patients At the Partnership for Safe Medicines we advocate for policies that reduce patients’ exposure to counterfeit medication. We believe that safety is paramount, and that no patient should ever have to wonder if the medicine they are dispensed is real. Cheaper medicine that comes with a worry about its safety is no medicine at all.…

Read More

Government Sentencing Memo, USA v Aaron Michael Thomas, February 24, 2025

March 21, 2025
Posted in , , ,

United States District Court Northern District of Oklahoma USA v Aaron Michael Thomas Government Sentencing Memo Filed February 2025 Read the document.

Read More

Plea Agreement, USA v Aaron Michael Thomas, November 27, 2024

March 21, 2025
Posted in , ,

PlUnited States District Court Northern District of Oklahoma USA v Aaron Michael Thomas Plea Agreement Filed November 2024 Read the document.

Read More

Information, USA v Aaron Michael Thomas, November 21, 2024

March 21, 2025
Posted in , , ,

United States District Court Northern District of Oklahoma USA v Aaron Michael Thomas Information Filed November 2024 Read the document.

Read More